Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sonova Holding AGXSWX:SOON -0.87%89 EV-to-EBIT is 19.71 as of Jul. 19, 2026, which is 22% below its 10-year median of 25.20. GuruFocus rates XSWX:SOON with a GF Score™ of 89/100 and a GF Value™ of CHF250.57 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 465 Medical Devices & Instruments companies, Sonova Holding AG ranks worse than 53.33% on this metric.
The historical rank and industry rank for Sonova Holding AG's EV-to-EBIT or its related term are showing as below:
XSWX:SOON'
s EV-to-EBIT Range Over the Past 10 Years
Min: 16.1 Med: 25.2 Max: 40.72
Current: 19.71
During the past 13 years, the highest EV-to-EBIT of Sonova Holding AG was 40.72. The lowest was 16.10. And the median was 25.20.
XSWX:SOON's EV-to-EBIT is ranked worse than 53.33% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 18.43
vs XSWX:SOON: 19.71
Sonova Holding AG (XSWX:SOON) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Sonova Holding AG's Enterprise Value for the quarter that ended in Mar. 2026 was CHF11,645 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sonova Holding AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was CHF670 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sonova Holding AG EV-to-EBIT Related Terms
Sonova Holding AG EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Sonova Holding AG's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Sonova Holding AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sonova Holding AG EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sonova Holding AG's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Sonova Holding AG's EV-to-EBIT falls into.
Sonova Holding AG's current Enterprise Value is CHF13,213 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sonova Holding AG's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was CHF670 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sonova Holding AG (XSWX:SOON) has a EV-to-EBIT of 19.71 as of Jul. 19, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Sonova Holding AG and its competitors. This is 22% below median its historical median of 25.20. Over the past decade, Sonova Holding AG's EV-to-EBIT has ranged from 16.10 to 40.72. According to the industry distribution chart, Sonova Holding AG ranks #248 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 53.3%.
Is Sonova Holding AG's EV-to-EBIT too high?
Sonova Holding AG's current EV-to-EBIT of 19.71 is 22% below median its 10-year median of 25.20. Over the past 10 years, this metric has ranged from a low of 16.10 to a high of 40.72. The Medical Devices & Instruments industry median EV-to-EBIT is 18.43. Sonova Holding AG's value of 19.71 is 6.9% above this industry median. Based on the distribution chart, Sonova Holding AG ranks #248 out of 465 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Sonova Holding AG has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonova Holding AG's EV-to-EBIT compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sonova Holding AG ranks #248 out of 465 companies for EV-to-EBIT. This places Sonova Holding AG in the lower half of its industry. The industry median EV-to-EBIT is 18.43. Sonova Holding AG's value of 19.71 is 6.9% above this benchmark. Historically, Sonova Holding AG's own EV-to-EBIT has ranged from 16.10 to 40.72 over the past decade. While the company's 10-year median is 25.20 vs. the industry median of 18.43, Sonova Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.43, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sonova Holding AG's current EV-to-EBIT of 19.71 is 6.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Sonova Holding AG and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sonova Holding AG's current EV-to-EBIT is 19.71, which is 22% below median its own 10-year median of 25.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonova Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Sonova Holding AG (XSWX:SOON) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF250.57, compared to a current price of CHF205.40 — trading 18% below its estimated fair value. The current EV-to-EBIT is 19.71, which is 22% below median its 10-year median of 25.20 and 6.9% above the Medical Devices & Instruments industry median of 18.43. Sonova Holding AG's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Sonova Holding AG (XSWX:SOON), the current EV-to-EBIT is 19.71 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sonova Holding AG (XSWX:SOON) Overvalued in 2026?
Based on GuruFocus' analysis, Sonova Holding AG stock appears to be undervalued.
The current stock price of CHF205.40 is trading 18% below its estimated GF Value™ of CHF250.57.
GuruFocus considers Sonova Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:SOON:
EV-to-EBIT: 19.71 (22% below median its 10-year median of 25.20)
GF Value™: CHF250.57 vs. price of CHF205.40 (18% below fair value)
Industry Position: 6.9% above the Medical Devices & Instruments median (#248 of 465)
No single metric tells the full story. See the XSWX:SOON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sonova is one of the world's largest manufacturers and distributors of hearing aids. The company is based in Switzerland and distributes its products in more than 100 countries through its internal sales team and independent retailers. It also sells cochlear implants and audio technologies.
89GF Score
Get the complete analysis for XSWX:SOON
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SOON has been successfully added to your 
